Multiple studies have found alterations in KMT2C and KMT2D, which encode histone methyltransferases, to be enriched in metastatic PCa cohorts as compared to primary PCa [9, 11, 31, 32, 39]. This evidence concerns the gene PRDM9 and posterior cortical atrophy.